Electronic Journal of General Medicine

• Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Diseases 1996; 22:5112–8.
• Pfaller MA. Nosocomial candidiasis. Emerging species, reservoirs and modes of transmission. Clin Infect Diseases 1996;22:S589–94.
• Cowen LE, Anderson JB, Kohn LM. Evolution of drug resistance in Candida albicans. Annual Review Microbiol 2002; 56:139-65.
• Ellis D. Amphotericin B : spectrum and resistance. J Antimicrob Chemoter 2002;49:7-10.
• Arikan S, Rex JH. Resistance to antifungal agents. In: Topley and Wilson’s Microbiology and Microbial infections: Medical Mycology 10th ed. Merz WG and Hay RJ eds. London: Hodder Arnold 2005:168-181.
• Peyron F, Favel A, Calaf R, Michel-Nguyen A, Bonaly R, Coulon J. Sterol and Fatty acid composition of Candida lusitaniae clinical isolates. Antimicrob Agents Chemother 2002;46:531-3.
• Ghannoum MA, Rice LB. Antifungal agents. Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999; 12: 501-17.
• Odds FC. Antifungal agents and thier use in Candida infections. In : Candida and candidosis 2nd ed. London:Billiere Tindall 1988: 279-313.
• Lambert HP and O’Grades FW. Antibiotic and chemotherapy 6th ed. London: Churchill- Livingstone 1992:27-37.
• White TC. Antifungal drug resistance in Candida albicans. ASM News 1997;63:427-33.
• Mishra NN, Prasad T, Sharma N, et al. Pathogenecity and drug resistance in Candida albicans and other yeast species – A review. Acta Microbial Immunol Hyg 2007;54:201- 35.
• Morschhauser J. The genetic basis of fluconazole resistance development in Candida albicans. Biochem Biophy Acta 2002;18:240-8.
• Prasad R, Kapoor K. Multidrug resistance in yeast Candida. Int Rev Cytol 2005;242:215-48.
• White TC, Hollemans, DY F, Mirels LF, Stevens DA. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002;46:1704-13.
• White TC, Marr KA, Bowden RA. Clinical, cellular and molecalr factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998;11:382-402.
• White TC. The presence of an R- 467 K amino acid substitution and loss of alleic variation correlate with an azole- resistant lanosterol 14 α demethylase in Candida albicans. Antimicrob Agents Chemother 1997;41:1488-94.
• Vonderbossche H, Dormer E, Improvisi I, et al. Antifungal drug resistance in pathogenic fungi. Med Mycol 1998;36(Suppl 1 ):119–28.
• Bossche HV, Warnock DE, Dupont B, et al. Mechanism and clinical impact of antifungal drug resistance. J Med Vet Mycol 1994;32(suppl 1):189-202.
• Maebashi K, Niimi M, Kudoh M, et al. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J antimicrob Chemother 2001;47:527-36.
• Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J. The ATP binding casssette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 1999;43:2753-65.
• Dignani M, Solomkin JS, Anaissie EJ. Candida in Clinical Mycology 2nd ed. Anaissic EJ, Mc Ginnis MR and Pfaller MA editors. Churchill- Livingstone–Elsevier 2009;197-229.
• Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Mechanism of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 1995;39:2378-86.
• Sanglard D, Ischer F, Monod M, Bille J. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 1996;40:2300-5.
• Groll AH, Walsh UJJ. Potential new antifungal agents. Current Opinions in Infectious Diseases 1997;10:449-58.

Vancouver

Sheikh N, Jahagirdar V, Kothadia S, Nagoba B. Antifungal Drug Resistance in Candida Species. EUR J GEN MED. 2013;10(4):254-8. https://doi.org/10.29333/ejgm/82217

APA

Sheikh, N., Jahagirdar, V., Kothadia, S., & Nagoba, B. (2013). Antifungal Drug Resistance in Candida Species. European Journal of General Medicine, 10(4), 254-258. https://doi.org/10.29333/ejgm/82217

AMA

Sheikh N, Jahagirdar V, Kothadia S, Nagoba B. Antifungal Drug Resistance in Candida Species. EUR J GEN MED. 2013;10(4), 254-258. https://doi.org/10.29333/ejgm/82217

Chicago

Sheikh, Nasira, Vilas Jahagirdar, Sarita Kothadia, and Basavraj Nagoba. "Antifungal Drug Resistance in Candida Species". European Journal of General Medicine 2013 10 no. 4 (2013): 254-258. https://doi.org/10.29333/ejgm/82217

Harvard

Sheikh, N., Jahagirdar, V., Kothadia, S., and Nagoba, B. (2013). Antifungal Drug Resistance in Candida Species. European Journal of General Medicine, 10(4), pp. 254-258. https://doi.org/10.29333/ejgm/82217

MLA

Sheikh, Nasira et al. "Antifungal Drug Resistance in Candida Species". European Journal of General Medicine, vol. 10, no. 4, 2013, pp. 254-258. https://doi.org/10.29333/ejgm/82217